News — Drug Delivery


Beyond Infertility: Progesterone for Menopause, PCOS, and Endometriosis
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When you hear the word “progesterone”, the hormone’s role in fertility treatments may be the first thing that comes to mind. After all, it’s “pro” “gest.” Get it? However, progesterone is not just for women trying to conceive—it also has a critical role in the management of other conditions that affect women throughout their lives. …

Kick-off clinical study meeting with UHCW

Delighted to have had a fantastic in-person kick-off meeting with our clinical trial partners at University Hospitals Coventry and Warwickshire NHS Trust. After many months of productive online prep, it was energising to gather with such an incredible team to advance our work. We at Calla Lily Clinical Care are very excited to be collaborating …

Why Intravaginal Progesterone Therapy is a Smart Choice and a Smart Investment
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Progesterone therapy is a crucial part of women’s reproductive health, particularly in fertility treatments, endometriosis management, and menstrual regulation. I took it when I was trying to get pregnant and I took it when I was trying to stop bleeding through my clothes (thanks fibroids!) and I took it as part of my journey through …

Funded PhD–</span> Vaginal probiotics for reproductive health: microbiome organ-chip

Calla Lily Clinical Care is delighted to partner with Queen Mary University for this fully funded (incl student stipend) four-year PhD starting September 2025 as part of the EPSRC Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) cohort training programme. The COaCT is a 4-year PhD cohort training programme, co-delivered with key …

6 Lessons I Learned from Attending PODD and the MidAtlantic Capital Conference
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …

Funded MSc + PhD Studentship: Delivery of live biotherapeutics for restoration of women’s reproductive health

Calla Lily Clinical Care is delighted to partner with the University of Warwick for this fully funded (incl student stipend) four-year iCASE studentship from September 2025, available as part of Warwick’s MRC-funded Doctoral Training Partnership (DTP). Vaginal microbiota play a key role in women’s reproductive health. Disruption of the normal vaginal microbiome is associated with inflammation …

A Look at Three Common Medications That Can Be Delivered Intravaginally
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When one thinks about yeast infections, menopause and fertility support, the conversation usually revolves around pills or injections. But there’s a better, more targeted way to achieve results. The era of blanket treatments is fading. I used to joke that medicine isn’t Burger King–you can’t just have it your way. Except, that’s exactly what is …

Professor Andy Lewis presents at PODD 2024 in Boston

We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily.   Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …

Why Intravaginal Drug Delivery Is the Future of Women’s Health
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …

Pitching at the Merck Innovation Challenge
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.